Invention Grant
- Patent Title: Compositions and methods for inhibiting expression of the LECT2 gene
-
Application No.: US17268206Application Date: 2019-08-15
-
Publication No.: US11987792B2Publication Date: 2024-05-21
- Inventor: Gregory Hinkle , Huilei Xu
- Applicant: ALNYLAM PHARMACEUTICALS, INC.
- Applicant Address: US MA Cambridge
- Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee: ALNYLAM PHARMACEUTICALS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: Womble Bond Dickinson (US) LLP
- International Application: PCT/US2019/046657 2019.08.15
- International Announcement: WO2020/037125A 2020.02.20
- Date entered country: 2021-02-12
- Main IPC: C12N15/113
- IPC: C12N15/113 ; A61K9/00 ; A61K9/08 ; A61K9/51 ; A61K31/7125 ; A61K47/02 ; C07H21/02
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) compositions targeting the LECT2 gene, and methods of using such dsRNA compositions to alter (e.g., inhibit) expression of LECT2.
Public/Granted literature
- US20210348162A1 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE LECT2 GENE Public/Granted day:2021-11-11
Information query
IPC分类:
